Podcasts about cardiology foundation

Niraj Sharma, MD, FHRS, Northside Hospital is joined by Rhea Pimentel, BChir, MD, FHRS, University of Kansas Health System and Usman Siddiqui, MD, Florida Cardiology Advent Health Systems, Orlando, to discuss how the FLUTFIB study aimed to assess the incidence, duration, timing, and symptoms of atrial fibrillation (AF) after cavotricuspid isthmus (CTI) ablation in patients with atrial flutter (AFL). The study included 100 patients with AFL, who received implantable loop recorders for continuous AF monitoring following CTI ablation. Over a median follow-up of 24 months, 77% of patients experienced AF episodes, typically occurring around 180 days post-ablation. Most AF episodes lasted over an hour, and about half of the patients reported symptoms. Baseline characteristics and risk scores (HATCH and CHA2DS2-VASc) did not predict AF development. Oral anticoagulation was discontinued in 32% of patients during follow-up but was restarted in 15% after AF detection. No strokes or transient ischemic attacks were recorded. This study, the largest of its kind, underscores the high incidence of often asymptomatic AF after AFL ablation and provides insights for anticoagulation management post-ablation.   https://www.hrsonline.org/education/TheLead Host Disclosure(s): N. Sharma: Nothing to disclose.   Contributor Disclosure(s): U. Siddiqui: Honoraria/Speaking/Teaching: Abbott Medical, Acutus Medical Inc., Impulse Dynamics USA R. Pimentel: Honoraria/Speaking/Consulting: American College of Cardiology Foundation, Honoraria/Speaking/Teaching: Medtronic, Boston Scientific, Abbott Medical, Membership on Advisory Boards: Biosense Webster This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365 https://www.heartrhythm365.org/URL/TheLeadEpisode74

Pyrlcasts, brought to you by Pyrls.com! We take a closer look at interesting and relevant clinical topics related to pharmacotherapy. Want to learn more clinical pearls? Boost your clinical confidence? Visit and sign-up for an account at pyrls.com to get over 10 high-quality charts absolutely FREE! Episode References: Center for Behavioral Health Statistics and Quality. (2021). Results from the 2020 National Survey on Drug Use and Health: Detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/ COCAINE HYDROCHLORIDE NASAL solution. Lannett Company, Inc. Accessed via DailyMed. Updated August 27, 2020. Zimmerman JL. Cocaine intoxication. Crit Care Clin. 2012;28(4):517-526. doi:10.1016/j.ccc.2012.07.003 Richards JR, Hollander JE, Ramoska EA, et al. β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon. J Cardiovasc Pharmacol Ther. 2017;22(3):239-249. doi:10.1177/1074248416681644 Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in J Am Coll Cardiol. 2013 Sep 10;62(11):1040-1]. J Am Coll Cardiol. 2013;61(23):e179-e347. doi:10.1016/j.jacc.2013.01.014 Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014 Dec 23;130(25):e433-4. Dosage error in article text]. Circulation. 2014;130(25):e344-e426. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation [published correction appears in Circulation. 2015 Apr 14;131(15):e408]. Circulation. 2011;124(22):2458-2473. doi:10.1161/CIR.0b013e318235eb4d Richards JR, Laurin EG. Cocaine. [Updated 2022 May 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430769/ Lo KB, Virk HUH, Lakhter V, et al. Clinical Outcomes After Treatment of Cocaine-Induced Chest Pain with Beta-Blockers: A Systematic Review and Meta-Analysis. Am J Med. 2019;132(4):505-509. doi:10.1016/j.amjmed.2018.11.041

Good Works: Episode 3 - Angelle Bourgeois, Louisiana Pediatric Cardiology Foundation by Louisiana Association of Business and Industry

Be sure to subscribe on your mobile device - search 'JNC/ASNC Podcast'. Fadi Hage and Pradeep Bhambhvani provide a ‘quick glance’ at some of the highlights from our forthcoming May-June 2019 issue. The articles discussed can be found at the following links: - S. S. Koenders & J. A. van Dalen et al. Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification. http://bit.ly/2Pr3Bqc - Maria Sciammarella & Elias H. Botvinick et al. A combined static-dynamic single-dose imaging protocol to compare quantitative dynamic SPECT with static conventional SPECT. http://bit.ly/2ICHDQt - Wael AlJaroudi & Rami Doukky et al. The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation. http://bit.ly/2UQh8NU - Anastasiya Bagrova & David E. Winchester et al. Comparing two methods for determining appropriateness of myocardial perfusion imaging: Criteria from the American College of Cardiology Foundation and the American College of Radiology. http://bit.ly/2PriVDb - Alberto Bestetti & Federico Lombardi et al. Additional value of systolic wall thickening in myocardial stunning evaluated by stress-rest gated perfusion SPECT. http://bit.ly/2VnsJ6y - Alessia Gimelli & Alessia Pepe et al. Evaluation of left ventricular mass on cadmium-zinc-telluride imaging: Validation against cardiac magnetic resonance. http://bit.ly/2VjJ5xd - Massimo Imbriaco & Alberto Cuocolo et al. Assessment of acute myocarditis by cardiac magnetic resonance imaging: Comparison of qualitative and quantitative analysis methods. http://bit.ly/2ICXWNl - Jesse F. Veenis & Arend F. L. Schinkel et al. Prediction of long-term (> 10 year) cardiovascular outcomes in heart transplant recipients: Value of stress technetium-99m tetrofosmin myocardial perfusion imaging. http://bit.ly/2L8U7l8 - Kjersti Johnsrud & Mona-Elisabeth Revheim et al. 18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques. http://bit.ly/2ZvJTOL - Maryam Mahmood & M. Rizwan Sohail et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. http://bit.ly/2Zsqrm5

This month's episode of EMplify, the podcast corollary to the Emergency Medicine Practice journal, focuses on acute decompensated heart failure. Hosts Jeff Nusbaum, MD, and Nachi Gupta, MD, cover all aspects of the acute management of this condition, from initial diagnosis and treatment in the emergency department to novel biomarkers and new and controversial therapies. The podcast is based on the full-length review published in the May 2017 issue of Emergency Medicine Practice. In it, co-authors Emily Singer Fisher, MD, and Boyd Burns, DO, FACEP, FAAEM, both of the University of Oklahoma School of Community Medicine, cover evidence published in 190 articles, and 10 reviews from the Cochrane database, as well as current guidelines issued by the American Heart Association and the American College of Cardiology Foundation. Topics covered in this episode of EMplify include Basics of acute decompensated heart failure Key differences in the pathophysiology of heart failure with reduced ejection fraction and heart failure with preserved ejection fraction Prehospital Care Initial ED Evaluation of acute decompensated heart failure Narrowing down the differential Physical exam best practices Diagnostic Studies Pulmonary ultrasound Cardiac ultrasound Treatment Lab markers Management of acute decompensated heart failure Role of early revascularization New and novel therapies Disposition Summary of the key points Links and resources: Tables referenced in this podcast episode - https://www.ebmedicine.net/topics.php?paction=showTopicSeg&topic_id=541&seg_id=8977 Noninvasive Ventilation For Patients In Acute Respiratory Distress: An Update - https://www.ebmedicine.net/topics.php?paction=showTopic&topic_id=532 Clinical Decision Making in Emergency Medicine - http://www.clinicaldecisionmaking.com/

This month's episode of EMplify, the podcast corollary to the Emergency Medicine Practice journal, focuses on acute decompensated heart failure. Hosts Jeff Nusbaum, MD, and Nachi Gupta, MD, cover all aspects of the acute management of this condition, from initial diagnosis and treatment in the emergency department to novel biomarkers and new and controversial therapies. The podcast is based on the full-length review published in the May 2017 issue of Emergency Medicine Practice. In it, co-authors Emily Singer Fisher, MD, and Boyd Burns, DO, FACEP, FAAEM, both of the University of Oklahoma School of Community Medicine, cover evidence published in 190 articles, and 10 reviews from the Cochrane database, as well as current guidelines issued by the American Heart Association and the American College of Cardiology Foundation. Topics covered in this episode of EMplify include Basics of acute decompensated heart failure Key differences in the pathophysiology of heart failure with reduced ejection fraction and heart failure with preserved ejection fraction Prehospital Care Initial ED Evaluation of acute decompensated heart failure Narrowing down the differential Physical exam best practices Diagnostic Studies Pulmonary ultrasound Cardiac ultrasound Treatment Lab markers Management of acute decompensated heart failure Role of early revascularization New and novel therapies Disposition Summary of the key points Links and resources: Tables referenced in this podcast episode - https://www.ebmedicine.net/topics.php?paction=showTopicSeg&topic_id=541&seg_id=8977 Noninvasive Ventilation For Patients In Acute Respiratory Distress: An Update - https://www.ebmedicine.net/topics.php?paction=showTopic&topic_id=532 Clinical Decision Making in Emergency Medicine - http://www.clinicaldecisionmaking.com/

On this week's News & Views we cover: NSAIDs like Ibuprofen, Celebrex, and Naproxen; new research that suggests high HDL is not heart protective; and how worrying about health can actually affect your health. The food for thought continues in the Moment of Paleo segment, which explores the things we cannot do when we must do them. After the Bell features a talk by Alan Watts on the topic of Double Binds. Links for this episode:Why & How to Support Latest in PaleoRecommended Food & Other ProductsRecommended Books & Audio BooksComment on this Episode or Share a News LinkCardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis — NEJMCelebrex arthritis drug just as safe as NSAIDs for pain relief, with fewer side effects, study finds - CBS NewsSurprise! Arthritis Drug Celebrex Shown As Safe As Ibuprofen And NaproxenIbuprofen May Not Be As Safe As You Think | TIMENew Study Reveals Ibuprofen and Naproxen Health RisksHigh-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study | Journal of the American College of Cardiology | American College of Cardiology FoundationDoes 'Good' Cholesterol Matter in Heart Disease Risk?: MedlinePlus Health NewsWhat you need to know about "good" HDL cholesterol - CBS NewsLow levels of HDL (the “good” cholesterol) appear connected to many health risks, not just heart disease - Harvard Health Blog - Harvard Health PublicationsBombshell health study: Raising HDL "good" cholesterol does not help prevent heart disease | Genetic Literacy ProjectHealth anxiety and risk of ischaemic heart disease: a prospective cohort study linking the Hordaland Health Study (HUSK) with the Cardiovascular Diseases in Norway (CVDNOR) project -- Berge et al. 6 (11) -- BMJ OpenWorrying about health increases heart disease risk - Medical News TodayCan worrying about your health make you ill? | Life and style | The GuardianWorried sick? Stressing that you'll get an illness can make you sick, study says - NBC NewsAlan Watts: The Double Bind - YouTubeVisit PuraKai to shop for eco-friendly clothing and stand-up paddle boards. Be sure to use coupon code "latest in paleo" for 15% off all clothing purchases.

Host: Jack Lewin, MD Guest: John Rumsfeld, MD, PhD So much of our clinical interaction with patients revolves around the collection, analysis and application of information. On a much broader scale, data registries work to assemble the information from each and every one of these clinical encounters. In this age of information, there is so much data at our fingertips, it is easy to be excited about the potential. How are we harnessing the information available to us, toward the improvement of clinical outcomes? Dr. John Rumsfeld, professor of medicine at the University of Colorado School of Medicine, and chief science officer for the National Cardiovascular Data Registry, an initiative led by the American College of Cardiology Foundation, talks with host Dr. Jack Lewin.

Host: Jack Lewin, MD Guest: John Rumsfeld, MD, PhD So much of our clinical interaction with patients revolves around the collection, analysis and application of information. On a much broader scale, data registries work to assemble the information from each and every one of these clinical encounters. In this age of information, there is so much data at our fingertips, it is easy to be excited about the potential. How are we harnessing the information available to us, toward the improvement of clinical outcomes? Dr. John Rumsfeld, professor of medicine at the University of Colorado School of Medicine, and chief science officer for the National Cardiovascular Data Registry, an initiative led by the American College of Cardiology Foundation, talks with host Dr. Jack Lewin.